| Date | Title | Description |
| 31.10.2024 | Ministers and Global Executives to Converge at the Second Edition of Gateway Gulf in Bahrain | MANAMA, Bahrain, Oct. 31, 2024 /PRNewswire/ -- Global industry leaders will converge in Bahrain for the highly anticipated second edition of the Gateway Gulf Investment Forum, scheduled to take place on November 3-4, 2024, at the Four Seaso... |
| 29.10.2024 | AbbVie’s Bold Move: Acquiring Aliada Therapeutics for CNS Breakthroughs | In a strategic maneuver that echoes the age-old adage, "the early bird catches the worm," AbbVie has set its sights on the burgeoning field of central nervous system (CNS) therapeutics. The Chicago-based pharmaceutical giant annou... |
| 29.10.2024 | Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY | -- Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candidate (SCB-1019) --
-- RSV neutralizing antibodies for Clover's non-adjuvanted SCB-1019 ma... |
| 28.10.2024 | South Africa’s ‘Pick n Pay’ to exit Nigeria after selling 51% stake in its joint venture | South African grocery retailer Pick n Pay is set to exit the Nigerian market by selling its 51% stake in a joint venture, as part of a broader restructuring strategy outside its home market, CEO Sean Summers announced on Monday as reported ... |
| 24.10.2024 | Pennsylvania Gets it Done: Governor Shapiro, GSK Leadership Announce the Global Biopharma Company’s Investment of up to $800 Million in Pennsylvania, Expanding its Operations and Creating Jobs in the ... | The Commonwealth is investing $21 million in the Lancaster County project, which will create 200 new, high-paying jobs
As part of its largest U.S. manufacturing investment to date, GSK is increasing its R&D and manufacturing footprint —... |
| 23.10.2024 | Zantac Lawsuit Lawyer: What You Need to Know | Share
Tweet
Share
Share
Email
If you or a loved one took Zantac (ranitidine) and later developed health complications, particularly cancer, you may be entitled to legal compensation through a Zantac lawsuit. Due to increasing evidence linki... |
| 23.10.2024 | Syngene International’s CFO Sibaji Biswas resigns | Syngene International Limited’s Executive Director, Chief Financial Officer (CFO), Sibaji Biswas has resigned to pursue other career opportunities. He will be replaced by Deepak Jain effective from December 1.
The company said in its filing... |
| 21.10.2024 | Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases | The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.
The Cambridge-GSK Translational Immunology Collaboration (CG-TIC) combines University and GSK expert... |
| 18.10.2024 | Positive progress in addressing unmet medical needs |
The FDA has granted Fast Track designation to Neurimmune’s partner Alexion, AstraZeneca Rare Disease Fast Track designation for the development of ALXN2220 (formerly NI006) for the treatment of transthyretin amyloidosis with cardiomyopathy... |
| 17.10.2024 | The UK Work Visa: A Gateway for Global Talent in 2024 | The UK is opening its doors wider than ever. The UK Work Visa is the key. It unlocks a treasure trove of job opportunities for international workers. As the world shifts, the UK job market stands ready to welcome skilled individuals from al... |
| 16.10.2024 | UK Work Visa opens new opportunities for international workers in 2024 | The job market in the United Kingdom offers diverse opportunities, presenting numerous short-term work opportunities for international workers through the UK Work Visa.
Last Stop Booking informs that the average monthly salary for jobs in t... |
| 14.10.2024 | US Tech Giants To Invest £6.3BN in UK Data Centres | US firms CyrusOne, ServiceNow, Cloud HQ and CoreWeave have announced the UK will be the home for their data infrastructure, worth a total of £6.3 billion.
These new data centres will provide the UK with more computing power and data storage... |
| 10.10.2024 | Flip acquires The Bot Platform to merge their HR capabilities | Flip, an app for frontline employees, has today announced its acquisition of The Bot Platform, an enterprise software solution that helps HR and communication teams supercharge the way they work using bots, automated workflows, and AI agent... |
| 04.10.2024 | Frazier Life Sciences: Over $630 Million Added To Evergreen Public Fund | Frazier Life Sciences (FLS), a healthcare investment firm focused on innovative therapeutics, announced it has closed on over $630 million in capital commitments to its evergreen Public Fund from new and existing investors in an oversubscri... |
| 03.10.2024 | Tangible Continues Hiring Streak Adding Michelle Suttle as Chief Growth Officer | Customer experience consultancy Tangible (www.tangible.co) has added another industry heavy-hitter to its growing roster of talent. Effective immediately, Michelle Suttle joins the team as Chief Growth Officer, following long-term roles at ... |
| 02.10.2024 | Pfizer's Strategic Shift: Selling Haleon Shares and Precision Medicine's New Leadership | In the ever-evolving landscape of pharmaceuticals, companies often pivot to stay ahead. Pfizer is making waves again. The pharmaceutical giant has announced a significant move: selling its stake in Haleon, the maker of Sensodyne, for a stag... |
| 01.10.2024 | Pfizer продает свою долю в производителе Sensodyne Haleon стоимостью $3,3 млрд | Компания Pfizer, которая после продажи остается крупнейшим акционером Haleon, в прошлом году заявила, что планирует сократить свою долю владения «медленно и методично» в течение нескольких месяцев.
Американский фармацевтический гигант намер... |
| 01.10.2024 | Precision Medicine Group Welcomes Margaret Keegan as CEO | -- Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors --
BETHESDA, Md., Oct. 1, 2024 /PRNewswire/ -- Precision Medicine Group (Precision), a leading next-generation provider... |
| 27.09.2024 | Bridging Gaps: Innovative Solutions for Youth and Health in America | In the heart of America, two pressing issues emerge: youth violence and the health of older adults. Both demand innovative solutions. The stories from Denver and Malaysia illustrate how communities can respond effectively.
In Denver, a new ... |
| 26.09.2024 | Navigating the New Frontier: Innovations in E-commerce and Application Development | In the fast-paced world of e-commerce and technology, two recent developments stand out like beacons in a storm. Carbon6 has launched a new solution for Walmart suppliers, while Platformatic has secured funding to enhance Node.js applicatio... |
| 25.09.2024 | GSK's Arexvy is a vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia | Adults aged 60 and over with underlying co-morbidities are at high risk of developing severe infections from RSV
Vaccine showed 82.6% overall vaccine efficacy against RSV-LRTD with 94.6% efficacy observed in adults with co-morbidities vii
K... |
| 23.09.2024 | Carbon6 Launches 1P Deduction Management Solution for Walmart Suppliers | Carbon6, a global leader in ecommerce software solutions, has announced its 1P Deduction Management solution for Walmart suppliers. The new solution empowers suppliers to efficiently identify and recover deductions stemming from carton shor... |
| 20.09.2024 | Coca-Cola's Bold Bet on Nigeria: A $1 Billion Investment Amid Economic Turbulence | Coca-Cola is making waves in Nigeria. The beverage giant has announced a staggering $1 billion investment in its operations over the next five years. This bold move comes at a time when the Nigerian economy is grappling with inflation, curr... |
| 20.09.2024 | Why Coca-cola suspended its 5-year $1 billion investment pledge to Nigeria in 2021 – Presidency | The presidency has clarified the reasons behind Coca-Cola’s withdrawal of its 5-year, $1 billion investment pledge to Nigeria, which was made in 2021.
The Special Adviser to the President on Information and Strategy, Bayo Onanuga, disclosed... |
| 20.09.2024 | Airing the unknown impact of RSV | Listen to this article
Airing the unknown impact of RSV
1 min
New: You can now listen to articles.
This audio is generated by an AI tool.
In Singapore’s humid climate, where respiratory illnesses can spread year-round, respiratory syncytial... |
| 19.09.2024 | Coca-Cola plans to invest $1 billion in Nigeria operations, presidency says | Retail & ConsumerCoca-Cola plans to invest $1 billion in Nigeria operations, presidency says
By ReutersSeptember 19, 20247:04 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A man walks past... |
| 16.09.2024 | Circle Pharma Expands Leadership Team to Drive the Development of Its Pipeline of Oral Macrocycle Therapies | SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–September 16, 2024–
Circle Pharma, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced ... |
| 14.09.2024 | Nigerian businesses need to be creative to survive inflation, high rates – Olufemi Oyinsan, TCVP General Partner | In an era of soaring inflation and escalating interest rates, Nigerian businesses are facing unprecedented challenges in maintaining profitability and securing capital. Olufemi Oyinsan, General Partner at The Continent Venture Partners (TCV... |
| 13.09.2024 | Navigating the Safety Landscape: Singapore's New Workplace Safety Initiative | In the bustling heart of Singapore, a new initiative is reshaping the landscape of workplace safety. The Workplace Safety and Health (WSH) Council has appointed major firms as advocates to elevate safety standards among contractors. This pr... |
| 13.09.2024 | GSK shingles vaccine now available in Malaysia | A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk
KUALA LUMPUR, Malaysia, Sept. 13, 2024 /PRNewswire/ -- GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch ... |
| 12.09.2024 | Moderna expects up to $3.5 billion in 2025 sales | Healthcare & PharmaceuticalsCommercial Strategy
Public Health
Moderna expects up to $3.5 billion in 2025 sales
By Patrick WingroveSeptember 12, 202410:15 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin... |
| 12.09.2024 | Making workplaces safer: Some large firms appointed as advocates to encourage safety among contractors | Listen to this article
Making workplaces safer: Some large firms appointed as advocates to encourage safety among contractors
1 min
New: You can now listen to articles.
This audio is generated by an AI tool.
SINGAPORE: Industrial contractor... |
| 04.09.2024 | Gabriel Millan joins Mars as Chief Financial Officer for Petcare business | Mars announces Gabriel Millan as new CFO for Petcare, Millan will join the Mars Petcare Leadership Team and global Finance Leadership Team
Recognized finance leader with over 25 years' experience in Fortune-500/FTSE-100 companies across con... |
| 03.09.2024 | Pharmaceutical Market: Trends, Segmentation, and Growth Opportunities | Share
Tweet
Share
Share
Email
In recent years, the pharmaceutical market has witnessed remarkable growth and transformation, driven by technological advancements, evolving consumer needs, and the global push for better healthcare solutions.... |
| 03.09.2024 | Parkinson’s Disease Drug Market: Trends, Growth, and Segmentation | Share
Tweet
Share
Share
Email
Parkinson’s disease, a progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia, affects millions of individuals worldwide. As the global population age... |
| 03.09.2024 | Ovarian Cancer Research Alliance (OCRA) Champions Access and Equity in Ovarian Cancer and Gynecologic Cancer Awareness Month | NEW YORK, Sept. 3, 2024 /PRNewswire/ -- As Ovarian and Gynecologic Cancer Awareness Month begins, Ovarian Cancer Research Alliance (OCRA) is proud to highlight a series of initiatives aimed at expanding access and promoting equity in ovaria... |
| 29.08.2024 | The Future of Pharmaceuticals: Navigating Price Negotiations and Patient Access | The landscape of pharmaceuticals is shifting. The winds of change are blowing through Wall Street and the healthcare system alike. As the U.S. government prepares for drug price negotiations under the Inflation Reduction Act, the stakes are... |
| 28.08.2024 | Cerebras Launches the World’s Fastest AI Inference | 20X performance and 1/5th the price of GPUs- available today Developers can now leverage the power of wafer-scale compute for AI inference via a simple API
Cerebras Systems, the pioneer in high performance AI compute, announced Cerebras Inf... |
| 23.08.2024 | Ozempic on Wall Street's list for 2027 Medicare drug negotiations | Future of HealthOzempic on Wall Street's list for 2027 Medicare drug negotiations
By Michael ErmanAugust 23, 202412:06 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A box of Ozempic made by No... |
| 20.08.2024 | GSK receives US breakthrough therapy designation for lung cancer treatment | - |
| 18.08.2024 | GlaxoSmithKline K.K. GSK launches two new TV commercials aimed at raising awareness about the disease and prev ention of shingles: “Why don’t you ask me about it? About shingles” and “Who knew it was ... | GlaxoSmithKline K.K.
GSK will begin airing two new TV commercials nationwide on August 19th, aimed at raising awareness about the disease and prevention of shingles.
……
・TV commercial to raise awareness about the disease and prevention of s... |
| 18.08.2024 | GlaxoSmithKline K.K. GSK launches two new TV commercials aimed at raising awareness about the disease and prev ention of shingles: “Why don’t you ask me about it? About shingles” and “Who knew it was ... | - |
| 13.08.2024 | Myrobalan Therapeutics: Additional $9 Million Raised And Grant Bogle Joins Board | Myrobalan Therapeutics, a biotechnology company developing novel oral small-molecule therapies to repair damage and restore brain function in high-unmet need central nervous system (CNS) conditions, announced the appointment of Grant C. Bog... |
| 09.08.2024 | GSK Group begins building relationships with alumni (retirees) using “Official-Alumni.com” provided by Hackazouk | Hackazouk Co., Ltd.
GSK Group begins building relationships with alumni (retirees) using “Official-Alumni.com” provided by Hackazouk
……
Using “Official-Alumni.com,” a specialized alumni service provided by Hackazouk Co., Ltd. (Headquarters:... |
| 09.08.2024 | GSK Group begins building relationships with alumni (retirees) using “Official-Alumni.com” provided by Hackazouk | - |
| 08.08.2024 | New Frontiers in Vaccine Development and Cancer Treatment: A Dual Breakthrough | In the realm of healthcare, two recent developments shine like beacons of hope. LimmaTech Biologics is making strides in vaccine development, while GSK is redefining cancer treatment. Both stories reveal the relentless pursuit of innovation... |
| 08.08.2024 | Battling Dementia: A New Dawn in Prevention and Treatment | Dementia looms like a dark cloud over aging populations. But recent studies illuminate pathways to fend off this relentless foe. Almost half of dementia cases could be prevented. This revelation is a beacon of hope. It shifts the focus from... |
| 08.08.2024 | The Battle Against Dementia: A New Dawn in Prevention and Awareness | Dementia looms like a shadow over millions. It’s a thief, stealing memories and identities. But recent studies shine a light on prevention. Almost half of dementia cases could be avoided. This revelation is a beacon of hope for families and... |
| 07.08.2024 | GSK's Jemperli (dostarlimab) plus chemotherapy approved in Singapore as the first frontline immuno-oncology treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer | Jemperli in combination with chemotherapy is the first immuno-oncology treatment approved in the frontline setting for this patient population in Singapore.[1,2]
Latest published local registry reported endometrial cancer as the fourth most... |
| 04.08.2024 | Research reveals that up to 22% of medicines in Africa are substandard or fake | A new study by researchers at Bahir Dar University in Ethiopia reveals that up to 22.6%-over one-fifth-of medicines in Africa are either fake or substandard, posing a significant risk to the continent’s fragile public health system.
The stu... |
| 02.08.2024 | Health | Almost half of dementia cases can be fended off, study says | Shingles vaccines may also slow down the condition, according to another study published in the journal Nature Medicine that linked GSK Plc’s Shingrix to later dementia onset. Focusing on prevention and delay would push back the day that su... |
| 02.08.2024 | LimmaTech to receive €10 million in exclusive licensing agreement |
LimmaTech Biologics is a clinical-stage startup developing vaccines for the prevention of life-threatening diseases such as Shigellosis which is caused by Shigella bacteria. Shigellosis is the second leading cause of fatal diarrheal diseas... |
| 31.07.2024 | Asian Markets React to BOJ Rate Hike Amid Global Economic Uncertainty | Asian markets are in a state of flux. The Bank of Japan (BOJ) has stirred the pot by raising interest rates, sending ripples through the financial landscape. Investors are now navigating a volatile sea, with the yen swinging wildly and tech... |
| 31.07.2024 | GSK Leverages Genedata Biologics as End-to-End Automation and Data Science Platform | Global biopharma leader drives digital innovation, data sciences, and next-generation automation approaches with Genedata's cloud-based Biopharma Platform
BASEL, Switzerland, July 31, 2024 /PRNewswire-PRWeb/ -- Genedata, a leading provider ... |
| 31.07.2024 | Morning Bid: BOJ hikes, Fed next | European MarketsMorning Bid: BOJ hikes, Fed next
By ReutersJuly 31, 20245:01 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 2 Japanese national flag is hoisted atop the headquarters o... |
| 30.07.2024 | CVS Health Faces Legal Storm as Investors Seek Justice | CVS Health Corporation is in the eye of a legal hurricane. Investors are rallying, ready to take a stand against what they claim is a web of deception spun by the company. The stakes are high, and the clock is ticking.
A class action lawsui... |
| 30.07.2024 | The New Frontier in Biotech: Partnerships and Innovations Shaping the Future of Medicine | In the ever-evolving landscape of biotechnology, partnerships are the lifeblood of innovation. Two recent collaborations highlight this trend: GSK's partnership with Flagship Pioneering and Autobahn Therapeutics' successful funding round. B... |
| 30.07.2024 | BioIVT Appoints Dr. Judith Dunn and Dr. Auro Nair to its Board of Directors | WESTBURY, N.Y., July 30, 2024 /PRNewswire/ -- BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the appointment of Dr. Judith Dunn and Dr. Auro Nair to its Board of Dir... |
| 29.07.2024 | GSK and Flagship Pioneering partner to discover novel medicines and vaccines | Collaboration brings together GSK disease area expertise and development capability with Flagship portfolio of 40+ bioplatform companies
Initial phase to identify and accelerate promising scientific concepts for further research starting in... |
| 29.07.2024 | GSK partners with Flagship Pioneering to develop medicines and vaccines | The two companies have agreed to jointly fund up to $150M upfront to identify promising concepts
Flagship Pioneering is a biotechnology company that creates and funds bioplatform companies; since its founded in 2000, it has developed more t... |
| 29.07.2024 | RSV vaccine makers vying for market share in second year of shots | Healthcare & PharmaceuticalsHealthcare Providers
RSV vaccine makers vying for market share in second year of shots
By Michael ErmanJuly 29, 20242:27 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Emai... |
| 23.07.2024 | Wantai’s Shares Sink After Chinese Vaccine Maker, UK’s GSK End HPV Jab Deal | (Yicai) July 23 -- Shares of Wantai Biological Pharmacy plunged after the Chinese firm said it and UK pharmaceutical giant GlaxoSmithKline had decided to terminate their agreement to develop a nine-valent papillomavirus vaccine.
Wantai [SHA... |
| 18.07.2024 | Asceneuron's $100M Series C Funding Boosts Alzheimer's Disease Research | Asceneuron, a Lausanne-based clinical-stage biotech company, has recently announced the successful completion of a $100 million Series C financing round. This significant funding boost, led by Novo Holdings and supported by EQT Life Science... |
| 16.07.2024 | Asceneuron closes $100 million series C financing round |
Asceneuron SA, a Lausanne-based clinical-stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, announces its $100 million oversubscribed Series C financing round. The... |
| 05.07.2024 | China’s pharmaceutical industry bets big on small nucleic acid drugs in 2024 | Nucleic acid drugs have emerged as a rapidly growing sector in recent years. However, following the Covid-19 pandemic, the messenger ribonucleic acid (mRNA) drug market, initially buoyed by mRNA vaccines, has quickly shrunk. Companies like ... |
| 03.07.2024 | UK economy ‘not as bad as is often assumed’ | - |
| 24.06.2024 | mRNA influenza vaccines – VacZine Analytics forecast a third of global market value in 2030 | This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global analysis of the seasonal influenza vaccine market including mRNA products (monovalent and combinations)
Annual s... |
| 19.06.2024 | Kong Names Joe Eskenazi Chief Revenue Officer | Kong Inc., a leading developer of cloud API technologies, today welcomed Joe Eskenazi as Chief Revenue Officer. Eskenazi will oversee Kong’s global sales organization, including Direct Sales, Sales Engineering, Sales and Business Developmen... |
| 18.06.2024 | Axtria Announces its First Ignite Leadership Award Honorees | Award Honors Top Executives Fueling Innovation and Impact in the Life Sciences Industry
BERKELEY HEIGHTS, N.J., June 18, 2024 /PRNewswire/ -- Axtria, a global leader in cloud software and data analytics for the life sciences industry, has a... |
| 18.06.2024 | Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults | -- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralizing antibody titers in older adults up to approximately 7,900 IU/mL (up to 8-fold increase) and approximately 46,700 IU/mL (up to 11-fold increase), respectively --
-- Favo... |
| 18.06.2024 | Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults | -- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralizing antibody titers in older adults up to approximately 7,900 IU/mL (up to 8-fold increase) and approximately 46,700 IU/mL (up to 11-fold increase), respectively --
-- Favo... |
| 10.06.2024 | WWDC 2024 Highlights: iOS 18 Brings Enhanced Privacy Controls to iPhone | By Quincy Jon
Published Jun 10, 2024 9:26PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
The Food and Drug Administration's (FDA) advisory committee endorsed Monday (June 10) El... |
| 10.06.2024 | GSK: Good news for pharma giant as approval granted to expand vaccine use | - |
| 07.06.2024 | FDA approves first RSV vaccine for at-risk adults in their 50s | The Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus down to age 50 years old, to those who are at higher risk of severe RSV, the company said Friday, making it the first shot greenlit for use i... |
| 04.06.2024 | Melissa Seymour to join Lilly as executive vice president of Global Quality | INDIANAPOLIS, June 4, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Melissa Seymour will join the company as executive vice president of Global Quality and member of the company's Executive Committee, effective... |
| 03.06.2024 | Sorry Britain, Europe’s just not that into you | - |
| 02.06.2024 | Sun Pharma expects high single-digit top line growth in the current fiscal: MD | Drug major Sun Pharmaceutical Industries expects a high single-digit top line growth in the current fiscal, according to Managing Director Dilip Shanghvi.
The Mumbai-based firm reported a consolidated total revenue from operations at ₹48,49... |
| 02.06.2024 | WHO members approve steps to bolster health regulations for pandemics | - |
| 02.06.2024 | Delaware judge allows more than 70,000 Zantac lawsuits to go forward | - |
| 31.05.2024 | Moderna's RSV vaccine for older adults approved | figcaption>span]:font-sans">
Moderna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting against the major respiratory threat.
Why it matte... |
| 30.05.2024 | US, UK in focus as pharma companies eye $31 billion exports in FY25 | - |
| 29.05.2024 | Over 100 business leaders back UK's opposition Labour Party before polls | - |
| 28.05.2024 | Точка пересечения благополучия сотрудников и HR-аналитики | Введение
В сегодняшней быстро развивающейся рабочей среде здоровье и благополучие сотрудников уже не просто желательное, а обязательное условие для компаний, стремящихся к успеху. Недавнее исследование, проведённое McKinsey, показало, что н... |
| 25.05.2024 | Efforts to draft pandemic treaty falter as countries disagree on steps | - |
| 25.05.2024 | AIM high: Why the London Stock Exchange still matters | - |
| 23.05.2024 | New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance | AMSTERDAM, May 23, 2024 /PRNewswire/ -- The race to create replacement antibiotics and antifungals to combat superbugs is falling dangerously short, putting people across the world at risk. However, a shift in research and development (R&am... |
| 23.05.2024 | SINGAPORE'S XSQUARE TECHNOLOGIES SECURES S$10.5M IN SERIES A FUNDING LED BY WAVEMAKER PARTNERS | SINGAPORE, May 23, 2024 /PRNewswire/ -- XSQUARE Technologies (XSQUARE), a Singapore-based intelligent warehousing automation company, has successfully raised S$ 10.5 million in Series A funding. The round was led by Wavemaker Partners–South... |
| 22.05.2024 | Healthcare sector most violative of advertisement rules, says Asci report | - |
| 21.05.2024 | Why one stockpicker thinks the FTSE 100 is ‘pregnant with value and opportunity’ | - |
| 21.05.2024 | GSK faces lawsuit from lab that found probable carcinogen in Zantac | - |
| 21.05.2024 | Time to give the UK’s golden goose some much-needed nurturing | - |
| 20.05.2024 | Syngulon and ULB announce the issuance by the USPTO of a first joint patent covering an antibiotic-free selection technology | Syngulon and ULB announce the issuance by the USPTO on March 19, 2024 of US Patent 11,932,672 covering an antibiotic-free selection technology based on bacteriocin/immunity for the production of recombinant protein or pDNA.
SERAING, Belgium... |
| 20.05.2024 | London Stock Exchange chief takes aim at ‘pernicious’ stamp duty on shares | - |
| 17.05.2024 | GSK raises £1.25bn as it offloads final stake in Haleon | GSK has offloaded the remainder of its stake in its former consumer goods division Haleon for £1.25bn today, severing the final ties between the two firms following a blockbuster de-merger two years ago.
In an announcement this morning, the... |
| 17.05.2024 | GSK Pharma Q4 results: Profit rises 45% on growth in NLEM drugs, vaccines | - |
| 16.05.2024 | HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1] | Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and... |
| 14.05.2024 | Could better inhalers help patients, and the planet? | Patients in the United States are prescribed roughly 144 million of what doctors call metered-dose inhalers each year, according to the most recently available data published in 2020. The cumulative amount of gas released is the equivalent ... |
| 14.05.2024 | Department of Health - Abu Dhabi partners with GSK to Establish Regional Vaccine Distribution Hub | ABU DHABI, UAE, May 14, 2024 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Memorandum of Understanding (MoU) with GSK, a leading biopharma company, during Abu... |
| 13.05.2024 | Amazon инвестирует $1,3 млрд во Францию и создаст 3000 рабочих мест | Президент Франции заявил в воскресенье, что Amazon и другие компании, включая GSK и Accenture, объявят об инвестициях на миллиарды долларов в рамках ежегодного мероприятия страны «Выберите Францию», которое начинается в понедельник.
Инвести... |
| 10.05.2024 | A strong start for Axmed |
Despite representing over 80% of the world's population, low- and middle-income countries (LMICs) account for a mere 6% of global pharmaceutical revenue, yet they represent a burgeoning $140 billion sector, with Africa alone accounting for... |
